15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering TuHURA Biosciences Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $8.00 to $10.00, so the covering firms are broadly aligned. The average target of $9.00 sits 323% above the current $2.13. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.13 next quarter toward $-0.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to TuHURA Biosciences Inc.
As of Jul, 3 of 3 firms rate HURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
HURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.13 – $-0.13 · 1 analysts · -7% YoY
Next period, 1 analysts expect TuHURA Biosciences Inc to earn $-0.13 a share (range $-0.13 – $-0.13), versus $-0.14 a year earlier. Full-year consensus is $-0.50, growing to $-0.56 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering TuHURA Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HURA.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Buy
$10.00+369.5% to target
Overall win rate
38%
+ Follow
#2
Jason McCarthy
Maxim Group · Rank #360
Buy
$8.00+275.6% to target
Overall win rate
30%
+ Follow
#3
ST
Silvan Turkcan
Citizens
Buy
$9.00+322.5% to target
Coverage
—
+ Follow
#4
MK
Michael King
Rodman & Renshaw
Buy
$7.00+228.6% to target
Coverage
—
+ Follow
#5
KR
Kumaraguru Raja
Brookline Capital Markets
Buy
$9.00+322.5% to target
Coverage
—
+ Follow
HURA stock forecast FAQ
What is HURA's average 12-month price target?+
The 2 analysts with a live target average $9.00 for TuHURA Biosciences Inc over the next 12 months, ranging from a $10.00 high to a $8.00 low.
Is HURA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for HURA?+
The Street-high target is $10.00 (HC Wainwright & Co.), and the Street-low is $8.00. The average of all 2 active targets is $9.00.
How many Wall Street analysts cover HURA?+
3 analysts have an active rating on TuHURA Biosciences Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering HURA?+
Among analysts who currently cover HURA, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #195). Their current call is Buy with a $10.00 target.
What is TuHURA Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.13 – $-0.13) across 1 analysts. Full-year EPS is projected at $-0.50, rising to $-0.56 the following year.
How much revenue is TuHURA Biosciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading HURA lately?+
As of Jul, 3 of 3 firms rate HURA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
